Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1780348

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1780348

Healthcare Analytical Testing Services Market By Testing Type, End User, Region - Global Forecast to 2030

PUBLISHED:
PAGES: 436 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The global healthcare analytical testing services market is projected to grow from USD 7.48 billion in 2025 to USD 12.48 billion by 2030, at a CAGR of 10.8% during the forecast period. The growing demand for quality assurance and compliance across industries, improvements in analytical techniques, and support from the government for investment and innovation are major factors anticipated to boost market growth. Additionally, the demand for customized testing solutions in new markets and the evolution in the regulatory environment are factors that contribute enormously to the increase in demand for analytical testing services.

Scope of the Report
Years Considered for the Study2023-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD billion)
SegmentsType, End User, and Region
Regions coveredNorth America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
Healthcare Analytical Testing Services Market - IMG1

By type, the bioanalytical testing services segment accounted for the largest share of the market in 2024.

Based on type, the healthcare analytical testing services market is segmented into physical characterization services, method development & validation services, stability testing services, bioanalytical testing services, batch-release testing services, raw material testing services, microbial testing services, genomic testing services, environmental monitoring services, and other analytical testing services. The bioanalytical testing services segment is further segmented into immunogenicity & neutralizing antibody testing, pharmacokinetic & toxicokinetic testing, biomarker testing, bioassay testing, and other bioanalytical testing services. The increasing R&D expenditure by biotechnology & pharmaceutical companies and the growing demand for biopharmaceuticals are expected to boost market growth in the study period.

By end user, the pharmaceutical companies segment accounted for the largest market share in 2024.

By end user, the market is segmented into pharmaceutical companies, biopharmaceutical companies, medical device companies, hospitals & clinics, forensic labs, cosmetic & nutraceutical companies, and other end users. The pharmaceutical companies segment accounted for the largest share of the market in 2024. The growth of this segment can be attributed to the increasing R&D expenditure of pharma & biopharma companies and the growing number of drug discovery & clinical trial projects.

The Asia Pacific region is expected to register the highest growth rate during the forecast period.

By region, the healthcare analytical testing services market covers North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific market is estimated to register the highest growth rate during the forecast period. The increasing outsourcing of drug discovery & development activities to emerging economies and the rising growth in the biopharmaceutical industry are expected to fuel growth in this region during the forecast period.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1 (45%), Tier 2 (30%), and Tier 3 (25%)
  • By Designation: Directors (42%), Managers (31%), and Others (27%)
  • By Region: North America (32%), Europe (32%), Asia Pacific (26%), Latin America (6%), Middle East & Africa (4%)

The prominent players in the healthcare analytical testing services market are Eurofins Scientific SE (Luxembourg), LabCorp Holdings Inc. (US), WuXi AppTec (China), Charles River Laboratories (US), SGS SA (Switzerland), Thermo Fisher Scientific Inc. (US), Medpace Holdings, Inc. (US), Sartorius AG (Germany), Intertek Group Plc (UK), Merck KGaA (Germany), SourceBio International Limited (UK), ICON Plc (Ireland), ALS (Australia), Frontage Labs (US), STERIS Plc (US), IQVIA (US), Element Materials Technology (UK), Pace Analytical Services (US), Almac Group (UK), and Pharmaron Beijing Co., Ltd. (China), among others.

Research Coverage

This report studies the healthcare analytical testing services market based on type, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will help both established companies and newcomers/smaller businesses understand the market dynamics, enabling them to increase their market share. Companies that purchase the report can use one or a combination of the strategies listed below to enhance their market presence.

This report provides insights on the following pointers:

  • Analysis of key drivers (stringent regulatory guidelines, growing focus on analytical testing of biologics & biosimilars, increasing outsourcing of analytical testing by pharmaceutical & medical device companies, increasing number of clinical trials, growing R&D expenditure in pharmaceutical & biopharmaceutical industry, and rising acceptance of quality-by-design approach in pharmaceutical research & manufacturing), restraints (increasing pressure on market players due to rising costs and market competition), opportunities (adoption of new techniques and technologies and growing focus on emerging economies), and challenges (shortage of skilled professionals, specific requirements for innovative formulations and medical devices, and need to improve sensitivity of bioanalytical methods) influencing the growth of the healthcare analytical testing services market.
  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the healthcare analytical testing services market.
  • Analytical Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and developments in the healthcare analytical testing services market.
  • Market Development: Comprehensive information on lucrative emerging regions.
  • Market Diversification: Exhaustive information about new services, growing geographies, and recent developments in the healthcare analytical testing services market.
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and services of the leading market players.
Show more
Product Code: AST 4341

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS & REGIONS COVERED
    • 1.3.2 REGIONS COVERED
    • 1.3.3 INCLUSIONS & EXCLUSIONS
    • 1.3.4 YEARS CONSIDERED
    • 1.3.5 CURRENCY CONSIDERED
  • 1.4 LIMITATIONS
    • 1.4.1 METHODOLOGY-RELATED LIMITATIONS
    • 1.4.2 SCOPE-RELATED LIMITATIONS
  • 1.5 MARKET STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH METHODOLOGY STEPS
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 List of secondary sources
      • 2.2.1.2 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
      • 2.2.2.1 Key data from primary sources
      • 2.2.2.2 Insights from primary experts
  • 2.3 MARKET ESTIMATION METHODOLOGY
    • 2.3.1 PRIMARY RESEARCH VALIDATION
  • 2.4 DATA TRIANGULATION AND MARKET BREAKDOWN
  • 2.5 RESEARCH ASSUMPTIONS
    • 2.5.1 STUDY ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET OVERVIEW
  • 4.2 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE & COUNTRY (2024)
  • 4.3 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: REGIONAL MIX, 2023-2030 (USD MILLION)

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Stringent regulatory guidelines
      • 5.2.1.2 Growing focus on analytical testing of biologics & biosimilars
      • 5.2.1.3 Increasing outsourcing of analytical testing services by pharmaceutical & medical device companies
      • 5.2.1.4 Rising number of clinical trials
      • 5.2.1.5 Growing R&D expenditure in pharmaceutical & biopharmaceutical industry
      • 5.2.1.6 Rising acceptance of quality-by-design approach in pharmaceutical research & manufacturing
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Increasing pressure on market players due to rising costs and market competition
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Adoption of new techniques and technologies
      • 5.2.3.2 Growing focus on emerging economies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Shortage of skilled professionals
      • 5.2.4.2 Specific requirements for innovative formulations and medical devices
      • 5.2.4.3 Challenges associated with ensuring bioanalytical testing sensitivity
  • 5.3 ECOSYSTEM ANALYSIS
  • 5.4 REGULATORY SCENARIO
    • 5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
    • 5.4.2 REGULATORY TRENDS
    • 5.4.3 NORTH AMERICA
    • 5.4.4 EUROPE
    • 5.4.5 ASIA PACIFIC
  • 5.5 VALUE CHAIN ANALYSIS
    • 5.5.1 SAMPLE MANAGEMENT & PREPARATION
    • 5.5.2 ANALYTICAL TESTING PROCEDURES
    • 5.5.3 DATA ANALYTICS & INTEGRATION
    • 5.5.4 QUALITY ASSURANCE & CONTROL
    • 5.5.5 CLIENT COMMUNICATION & SERVICE DELIVERY
  • 5.6 CASE STUDY ANALYSIS
    • 5.6.1 CASE STUDY 1: UNLOCKING POTENTIAL OF BIOPHARMACEUTICAL DEVELOPMENT THROUGH ANALYTICAL TESTING OUTSOURCING
    • 5.6.2 CASE STUDY 2: REVOLUTIONIZING PHARMACEUTICAL TESTING
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 THREAT OF NEW ENTRANTS
    • 5.7.2 BARGAINING POWER OF SUPPLIERS
    • 5.7.3 INTENSITY OF COMPETITIVE RIVALRY
    • 5.7.4 BARGAINING POWER OF BUYERS
    • 5.7.5 THREAT OF SUBSTITUTES
  • 5.8 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.8.2 KEY BUYING CRITERIA
  • 5.9 TECHNOLOGY ANALYSIS
    • 5.9.1 KEY TECHNOLOGIES
      • 5.9.1.1 Chromatography
      • 5.9.1.2 Mass spectrometry (MS)
      • 5.9.1.3 Spectroscopy
    • 5.9.2 COMPLEMENTARY TECHNOLOGIES
      • 5.9.2.1 Laboratory Information Management Systems (LIMS)
      • 5.9.2.2 Automation & robotics
      • 5.9.2.3 AI/ML in data analytics
    • 5.9.3 ADJACENT TECHNOLOGIES
      • 5.9.3.1 Single-use bioreactors
      • 5.9.3.2 mRNA technology
      • 5.9.3.3 Next-generation Sequencing (NGS)
  • 5.10 KEY CONFERENCES & EVENTS, 2024-2025
  • 5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.12 INVESTMENT & FUNDING SCENARIO
  • 5.13 UNMET NEEDS/END-USER EXPECTATIONS
  • 5.14 IMPACT OF AI/GENERATIVE AI ON HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
  • 5.15 TRUMP TARIFF IMPACT ON HEALTHCARE ANALYTICAL TESTING MARKET
    • 5.15.1 INTRODUCTION
    • 5.15.2 KEY TARIFF RATES
    • 5.15.3 PRICE IMPACT ANALYSIS
    • 5.15.4 KEY IMPACT ON VARIOUS REGIONS
      • 5.15.4.1 North America
      • 5.15.4.2 Europe
      • 5.15.4.3 Asia Pacific

6 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 BIOANALYTICAL TESTING SERVICES
    • 6.2.1 PHARMACOKINETIC & TOXICOKINETIC TESTING SERVICES
      • 6.2.1.1 Essential role in drug individualized dosing and therapeutic monitoring to drive market
    • 6.2.2 IMMUNOGENICITY & NEUTRALIZING ANTIBODY TESTING SERVICES
      • 6.2.2.1 Increasing requirement for drug safety approvals to fuel uptake
    • 6.2.3 BIOMARKER TESTING SERVICES SERVICES
      • 6.2.3.1 Growing preference for personalized medicine to fuel market
    • 6.2.4 BIOASSAY TESTING SERVICES
      • 6.2.4.1 Growing adoption of high-content screening for cytotoxicity testing to boost demand
    • 6.2.5 OTHER BIOANALYTICAL TESTING SERVICES
  • 6.3 PHYSICAL CHARACTERIZATION SERVICES
    • 6.3.1 LASER PARTICLE SIZE ANALYSIS SERVICES
      • 6.3.1.1 Growing importance of pharmaceutical dosage manufacturing to drive market
    • 6.3.2 THERMAL ANALYSIS SERVICES
      • 6.3.2.1 Advancements in thermal analysis techniques to support market growth
    • 6.3.3 OPTICAL CHARACTERIZATION SERVICES
      • 6.3.3.1 Increasing complexities of biological structures to boost demand
    • 6.3.4 SURFACE AREA ANALYSIS SERVICES
      • 6.3.4.1 Growing focus on streamlining drug development processes to fuel uptake
    • 6.3.5 OTHER PHYSICAL CHARACTERIZATION SERVICES
  • 6.4 METHOD DEVELOPMENT & VALIDATION SERVICES
    • 6.4.1 EXTRACTABLES/LEACHABLES METHOD DEVELOPMENT & VALIDATION SERVICES
      • 6.4.1.1 Adoption of parenterally administered drugs and biologics products to drive market
    • 6.4.2 PROCESS IMPURITY METHOD DEVELOPMENT & VALIDATION SERVICES
      • 6.4.2.1 Increasing emphasis on impurity testing to boost market
    • 6.4.3 STABILITY-INDICATING METHOD VALIDATION SERVICES
      • 6.4.3.1 Growing need to ensure safety & efficacy of drugs to drive market
    • 6.4.4 CLEANING VALIDATION & METHOD DEVELOPMENT SERVICES
      • 6.4.4.1 Focus on contamination reduction to fuel market
    • 6.4.5 ANALYTICAL STANDARD CHARACTERIZATION SERVICES
      • 6.4.5.1 Assessment of quantitative & qualitative accuracy to fuel uptake
    • 6.4.6 TECHNICAL CONSULTING SERVICES
      • 6.4.6.1 Stringent regulatory compliance to boost demand
    • 6.4.7 OTHER METHOD DEVELOPMENT & VALIDATION SERVICES
  • 6.5 RAW MATERIAL TESTING SERVICES
    • 6.5.1 COMPLETE COMPENDIAL TESTING SERVICES
      • 6.5.1.1 Need to determine efficacy & safety of therapeutic products to drive market
    • 6.5.2 CONTAINER TESTING SERVICES
      • 6.5.2.1 Optimization of sealing & evaluation of temperature impact to fuel uptake
    • 6.5.3 HEAVY METAL TESTING SERVICES
      • 6.5.3.1 Uptake of specialized equipment to support market growth
    • 6.5.4 WATER CONTENT ANALYSIS SERVICES
      • 6.5.4.1 Adequate moisture content analysis to fuel market
    • 6.5.5 OTHER RAW MATERIAL TESTING SERVICES
  • 6.6 BATCH-RELEASE TESTING SERVICES
    • 6.6.1 DISSOLUTION TESTING SERVICES
      • 6.6.1.1 Wide usage across formulation development & manufacturing applications to drive market
    • 6.6.2 ELEMENTAL IMPURITY TESTING SERVICES
      • 6.6.2.1 Rising need to minimize cost of in-house analysis to fuel market
    • 6.6.3 DISINTEGRATION TESTING SERVICES
      • 6.6.3.1 Ability to ensure batch-to-batch consistency of pharmaceutical dosage forms to fuel market
    • 6.6.4 HARDNESS TESTING SERVICES
      • 6.6.4.1 Measurement of tablet quality to support market growth
    • 6.6.5 FRIABILITY TESTING SERVICES
      • 6.6.5.1 Resistance measurement of tablets & granules to fuel market
    • 6.6.6 OTHER BATCH-RELEASE TESTING SERVICES
  • 6.7 STABILITY TESTING SERVICES
    • 6.7.1 DRUG SUBSTANCE STABILITY TESTING SERVICES
      • 6.7.1.1 Evidence testing on quality of pharmaceutical stability to fuel market
    • 6.7.2 FORMULATION EVALUATION STABILITY TESTING SERVICES
      • 6.7.2.1 Analysis of shelf life to fuel adoption
    • 6.7.3 ACCELERATED STABILITY TESTING SERVICES
      • 6.7.3.1 High stress conditions to provide enhanced results
    • 6.7.4 PHOTOSTABILITY TESTING SERVICES
      • 6.7.4.1 Systemic approach for ICH guideline adherence to propel market
    • 6.7.5 FORCED DEGRADATION TESTING SERVICES
      • 6.7.5.1 Rising need for comprehensive stability testing to drive market
    • 6.7.6 OTHER STABILITY TESTING SERVICES
  • 6.8 MICROBIAL TESTING SERVICES
    • 6.8.1 MICROBIAL LIMIT TESTING SERVICES
      • 6.8.1.1 Microbial quality efficacy testing to boost demand
    • 6.8.2 VIROLOGY TESTING SERVICES
      • 6.8.2.1 Increasing outbreaks of viral diseases to drive market
    • 6.8.3 STERILITY TESTING SERVICES
      • 6.8.3.1 Rising development of parenteral preparations and immunological products to drive market
    • 6.8.4 ENDOTOXIN TESTING SERVICES
      • 6.8.4.1 Endoxin-free testing to fuel market
    • 6.8.5 PRESERVATIVE EFFICACY TESTING SERVICES
      • 6.8.5.1 PET testing for toxicity to fuel uptake
    • 6.8.6 OTHER MICROBIAL TESTING SERVICES
  • 6.9 ENVIRONMENTAL MONITORING SERVICES
    • 6.9.1 AIR TESTING SERVICES
      • 6.9.1.1 Air contamination testing for quality checks to fuel market
    • 6.9.2 WASTEWATER/ETP TESTING SERVICES
      • 6.9.2.1 Need to minimize water contamination to fuel market
    • 6.9.3 OTHER ENVIRONMENTAL MONITORING TESTING SERVICES
  • 6.10 GENOMIC TESTING SERVICES
    • 6.10.1 DETECTION OF DISEASE MECHANISMS AND TREATMENT RESPONSES TO PROPEL MARKET
  • 6.11 OTHER ANALYTICAL TESTING SERVICES

7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER

  • 7.1 INTRODUCTION
  • 7.2 PHARMACEUTICAL COMPANIES
    • 7.2.1 GROWTH IN PHARMACEUTICAL INDUSTRY TO PROPEL MARKET
  • 7.3 BIOPHARMACEUTICAL COMPANIES
    • 7.3.1 INCREASING R&D INVESTMENTS TO FUEL MARKET
  • 7.4 MEDICAL DEVICE COMPANIES
    • 7.4.1 STRINGENT PRODUCT COMMERCIALIZATION GUIDELINES TO DRIVE MARKET
  • 7.5 HOSPITALS & CLINICS
    • 7.5.1 INCREASING INCIDENCE OF CHRONIC DISEASES TO BOOST DEMAND
  • 7.6 FORENSIC LABS
    • 7.6.1 RISING UTILIZATION OF ANALYTICAL TESTING TO FUEL MARKET
  • 7.7 COSMETIC & NUTRACEUTICAL COMPANIES
    • 7.7.1 RISING FOCUS ON QUALITY CONTROL TESTING TO FUEL UPTAKE
  • 7.8 OTHER END USERS

8 HEALTHCARE ANALYTICAL TESTING MARKET, BY REGION

  • 8.1 INTRODUCTION
  • 8.2 NORTH AMERICA
    • 8.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 8.2.2 US
      • 8.2.2.1 High number of pre-registration drugs in pipeline to drive market
    • 8.2.3 CANADA
      • 8.2.3.1 Presence of well-established CROs to support market growth
  • 8.3 EUROPE
    • 8.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 8.3.2 GERMANY
      • 8.3.2.1 Government support and flexible labor laws to boost demand
    • 8.3.3 FRANCE
      • 8.3.3.1 Favorable government regulations to drive market
    • 8.3.4 UK
      • 8.3.4.1 Increasing outsourcing of biopharmaceutical R&D to drive market
    • 8.3.5 ITALY
      • 8.3.5.1 Availability of drug discovery funding investments to fuel market
    • 8.3.6 SWITZERLAND
      • 8.3.6.1 High production of pharma drugs to fuel uptake
    • 8.3.7 SPAIN
      • 8.3.7.1 Rising number of clinical trials to boost demand
    • 8.3.8 REST OF EUROPE
  • 8.4 ASIA PACIFIC
    • 8.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 8.4.2 JAPAN
      • 8.4.2.1 Expanding geriatric population and increasing incidence of chronic diseases to propel market
    • 8.4.3 CHINA
      • 8.4.3.1 Increasing incidence of infectious diseases to boost demand
    • 8.4.4 INDIA
      • 8.4.4.1 Growing focus on establishment of genomic testing centers to drive market
    • 8.4.5 AUSTRALIA
      • 8.4.5.1 Large number of research institutes to support market uptake
    • 8.4.6 SOUTH KOREA
      • 8.4.6.1 Launch of innovative pharma drugs to boost demand
    • 8.4.7 REST OF ASIA PACIFIC
  • 8.5 LATIN AMERICA
    • 8.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 8.5.2 BRAZIL
      • 8.5.2.1 Rising adoption of emerging medical technologies to drive market
    • 8.5.3 MEXICO
      • 8.5.3.1 Favorable regulatory environment for API products to fuel market
    • 8.5.4 REST OF LATIN AMERICA
  • 8.6 MIDDLE EAST & AFRICA
    • 8.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 8.6.2 GCC COUNTRIES
      • 8.6.2.1 Improvements in healthcare infrastructure to boost demand
    • 8.6.3 REST OF MIDDLE EAST & AFRICA

9 COMPETITIVE LANDSCAPE

  • 9.1 OVERVIEW
  • 9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 9.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
  • 9.3 REVENUE ANALYSIS, 2020-2024
  • 9.4 MARKET SHARE ANALYSIS, 2024
  • 9.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 9.5.1 STARS
    • 9.5.2 EMERGING LEADERS
    • 9.5.3 PERVASIVE PLAYERS
    • 9.5.4 PARTICIPANTS
    • 9.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 9.5.5.1 Company footprint
      • 9.5.5.2 Region footprint
      • 9.5.5.3 Type footprint
      • 9.5.5.4 End-user footprint
  • 9.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 9.6.1 PROGRESSIVE COMPANIES
    • 9.6.2 RESPONSIVE COMPANIES
    • 9.6.3 DYNAMIC COMPANIES
    • 9.6.4 STARTING BLOCKS
    • 9.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 9.6.5.1 Detailed list of startups/SMEs
      • 9.6.5.2 Competitive benchmarking of emerging players/startups
  • 9.7 COMPANY VALUATION & FINANCIAL METRICS
    • 9.7.1 FINANCIAL METRICS
    • 9.7.2 COMPANY VALUATION
  • 9.8 BRAND/SERVICE COMPARISON
    • 9.8.1 BRAND/SERVICE COMPARATIVE ANALYSIS
  • 9.9 COMPETITIVE SCENARIO
    • 9.9.1 SERVICE LAUNCHES
    • 9.9.2 DEALS
    • 9.9.3 EXPANSIONS

10 COMPANY PROFILES

  • 10.1 KEY PLAYERS
    • 10.1.1 EUROFINS SCIENTIFIC SE
      • 10.1.1.1 Business overview
      • 10.1.1.2 Services offered
      • 10.1.1.3 Recent developments
        • 10.1.1.3.1 Deals
        • 10.1.1.3.2 Expansions
      • 10.1.1.4 MnM view
        • 10.1.1.4.1 Key strengths
        • 10.1.1.4.2 Strategic choices
        • 10.1.1.4.3 Weaknesses & competitive threats
    • 10.1.2 LABCORP HOLDINGS INC.
      • 10.1.2.1 Business overview
      • 10.1.2.2 Services offered
      • 10.1.2.3 Recent developments
        • 10.1.2.3.1 Services launches
        • 10.1.2.3.2 Deals
        • 10.1.2.3.3 Expansions
      • 10.1.2.4 MnM view
        • 10.1.2.4.1 Key strengths
        • 10.1.2.4.2 Strategic choices
        • 10.1.2.4.3 Weaknesses & competitive threats
    • 10.1.3 INTERTEK GROUP PLC
      • 10.1.3.1 Business overview
      • 10.1.3.2 Services offered
      • 10.1.3.3 Recent developments
        • 10.1.3.3.1 Deals
        • 10.1.3.3.2 Expansions
      • 10.1.3.4 MnM view
        • 10.1.3.4.1 Key strengths
        • 10.1.3.4.2 Strategic choices
        • 10.1.3.4.3 Weaknesses & competitive threats
    • 10.1.4 ICON PLC
      • 10.1.4.1 Business overview
      • 10.1.4.2 Services offered
      • 10.1.4.3 Recent developments
        • 10.1.4.3.1 Deals
      • 10.1.4.4 MnM view
        • 10.1.4.4.1 Key strengths
        • 10.1.4.4.2 Strategic choices
        • 10.1.4.4.3 Weaknesses & competitive threats
    • 10.1.5 IQVIA INC.
      • 10.1.5.1 Business overview
      • 10.1.5.2 Services offered
      • 10.1.5.3 Recent developments
        • 10.1.5.3.1 Expansions
        • 10.1.5.3.2 Other developments
      • 10.1.5.4 MnM view
        • 10.1.5.4.1 Key strengths
        • 10.1.5.4.2 Strategic choices
        • 10.1.5.4.3 Weaknesses & competitive threats
    • 10.1.6 WUXI APPTEC CO., LTD.
      • 10.1.6.1 Business overview
      • 10.1.6.2 Services offered
      • 10.1.6.3 Recent developments
        • 10.1.6.3.1 Service launches
        • 10.1.6.3.2 Deals
        • 10.1.6.3.3 Expansions
    • 10.1.7 CHARLES RIVER LABORATORIES
      • 10.1.7.1 Business overview
      • 10.1.7.2 Services offered
      • 10.1.7.3 Recent developments
        • 10.1.7.3.1 Service launches & approvals
        • 10.1.7.3.2 Deals
        • 10.1.7.3.3 Expansions
    • 10.1.8 SGS SA
      • 10.1.8.1 Business overview
      • 10.1.8.2 Services offered
      • 10.1.8.3 Recent developments
        • 10.1.8.3.1 Service launches
        • 10.1.8.3.2 Deals
        • 10.1.8.3.3 Expansions
        • 10.1.8.3.4 Other developments
    • 10.1.9 THERMO FISHER SCIENTIFIC INC.
      • 10.1.9.1 Business overview
      • 10.1.9.2 Services offered
      • 10.1.9.3 Recent developments
        • 10.1.9.3.1 Deals
        • 10.1.9.3.2 Expansions
    • 10.1.10 MEDPACE HOLDINGS, INC.
      • 10.1.10.1 Business overview
      • 10.1.10.2 Services offered
      • 10.1.10.3 Recent developments
        • 10.1.10.3.1 Deals
        • 10.1.10.3.2 Expansions
    • 10.1.11 SARTORIUS AG
      • 10.1.11.1 Business overview
      • 10.1.11.2 Services offered
      • 10.1.11.3 Recent developments
        • 10.1.11.3.1 Deals
        • 10.1.11.3.2 Expansions
    • 10.1.12 MERCK KGAA
      • 10.1.12.1 Business overview
      • 10.1.12.2 Services offered
      • 10.1.12.3 Recent developments
        • 10.1.12.3.1 Service launches
        • 10.1.12.3.2 Deals
        • 10.1.12.3.3 Expansions
        • 10.1.12.3.4 Other developments
    • 10.1.13 SOURCE BIOSCIENCE (SUBSIDIARY OF SOURCEBIO INTERNATIONAL PLC)
      • 10.1.13.1 Business overview
      • 10.1.13.2 Services offered
      • 10.1.13.3 Recent developments
        • 10.1.13.3.1 Service launches
        • 10.1.13.3.2 Expansions
    • 10.1.14 ALS
      • 10.1.14.1 Business overview
      • 10.1.14.2 Services offered
      • 10.1.14.3 Recent developments
        • 10.1.14.3.1 Deals
    • 10.1.15 FRONTAGE LABORATORIES, INC.
      • 10.1.15.1 Business overview
      • 10.1.15.2 Services offered
      • 10.1.15.3 Recent developments
        • 10.1.15.3.1 Deals
        • 10.1.15.3.2 Expansions
    • 10.1.16 STERIS PLC
      • 10.1.16.1 Business overview
      • 10.1.16.2 Services offered
      • 10.1.16.3 Recent developments
        • 10.1.16.3.1 Service launches
        • 10.1.16.3.2 Expansions
        • 10.1.16.3.3 Other developments
    • 10.1.17 ELEMENT MATERIALS TECHNOLOGY
      • 10.1.17.1 Business overview
      • 10.1.17.2 Services offered
      • 10.1.17.3 Recent developments
        • 10.1.17.3.1 Service launches
        • 10.1.17.3.2 Deals
        • 10.1.17.3.3 Expansions
        • 10.1.17.3.4 Other developments
    • 10.1.18 PACE ANALYTICAL SERVICES
      • 10.1.18.1 Business overview
      • 10.1.18.2 Services offered
      • 10.1.18.3 Recent developments
        • 10.1.18.3.1 Deals
        • 10.1.18.3.2 Expansions
    • 10.1.19 ALMAC GROUP
      • 10.1.19.1 Business overview
      • 10.1.19.2 Services offered
      • 10.1.19.3 Recent developments
        • 10.1.19.3.1 Service approvals
        • 10.1.19.3.2 Deals
        • 10.1.19.3.3 Expansions
    • 10.1.20 PHARMARON BEIJING CO., LTD.
      • 10.1.20.1 Business overview
      • 10.1.20.2 Services offered
      • 10.1.20.3 Recent developments
        • 10.1.20.3.1 Deals
  • 10.2 OTHER PLAYERS
    • 10.2.1 SYNEOS HEALTH
    • 10.2.2 PAREXEL INTERNATIONAL (MA) CORPORATION
    • 10.2.3 LGC LIMITED
    • 10.2.4 CELERION
    • 10.2.5 BIOAGILYTIX
    • 10.2.6 ALCAMI CORPORATION
    • 10.2.7 SAMSUNG BIOLOGICS
    • 10.2.8 CURIA GLOBAL, INC.
    • 10.2.9 BA SCIENCES
    • 10.2.10 AVANCE BIOSCIENCES

11 APPENDIX

  • 11.1 DISCUSSION GUIDE
  • 11.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 11.3 CUSTOMIZATION OPTIONS
  • 11.4 RELATED REPORTS
  • 11.5 AUTHOR DETAILS
Show more
Product Code: AST 4341

List of Tables

  • TABLE 1 INCLUSIONS & EXCLUSIONS
  • TABLE 2 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 3 PATENT EXPIRY OF BEST-SELLING BIOLOGICS
  • TABLE 4 IMPACT ANALYSIS: DRIVERS
  • TABLE 5 IMPACT ANALYSIS: RESTRAINTS
  • TABLE 6 IMPACT ANALYSIS: OPPORTUNITIES
  • TABLE 7 IMPACT ANALYSIS: CHALLENGES
  • TABLE 8 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: ROLE IN ECOSYSTEM
  • TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 ICH QUALITY GUIDELINES FOR PHARMACEUTICAL GMPS
  • TABLE 15 OVERVIEW OF GUIDELINES OF LABORATORY SERVICES
  • TABLE 16 DEVELOPMENT OF GLP ACROSS COUNTRIES
  • TABLE 17 REGULATORY AUTHORITIES AND LAUNCH OF GLP MONITORING PROGRAMS IN EUROPEAN COUNTRIES
  • TABLE 18 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
  • TABLE 20 KEY BUYING CRITERIA FOR HEALTHCARE ANALYTICAL TESTING SERVICES, BY RANK
  • TABLE 21 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DETAILED LIST OF LEADING CONFERENCES & EVENTS
  • TABLE 22 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: CURRENT UNMET NEEDS/END-USER EXPECTATIONS
  • TABLE 23 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 24 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 25 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 26 BIOANALYTICAL TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 27 PHARMACOKINETIC & TOXICOKINETIC TESTING SERVICES MARKET, BY REGION
  • TABLE 28 IMMUNOGENICITY & NEUTRALIZING ANTIBODY TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 29 BIOMARKER TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 30 BIOASSAY TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 31 OTHER BIOANALYTICAL TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 32 PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 33 PHYSICAL CHARACTERIZATION SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 34 LASER PARTICLE SIZE ANALYSIS SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 35 THERMAL ANALYSIS SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 36 OPTICAL CHARACTERIZATION SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 37 SURFACE AREA ANALYSIS SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 38 OTHER PHYSICAL CHARACTERIZATION SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 39 METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 40 METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 41 EXTRACTABLES/LEACHABLES METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 42 PROCESS IMPURITY METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 43 STABILITY-INDICATING METHOD VALIDATION SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 44 CLEANING VALIDATION & METHOD DEVELOPMENT SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 45 ANALYTICAL STANDARD CHARACTERIZATION SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 46 TECHNICAL CONSULTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 47 OTHER METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 48 RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 49 RAW MATERIAL TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 50 COMPLETE COMPENDIAL TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 51 CONTAINER TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 52 HEAVY METAL TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 53 WATER CONTENT ANALYSIS SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 54 OTHER RAW MATERIAL TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 55 BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 56 BATCH-RELEASE TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 57 DISSOLUTION TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 58 ELEMENTAL IMPURITY TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 59 BREAKDOWN OF DISINTEGRATION METHODS & IMMERSION MEDIA
  • TABLE 60 DISINTEGRATION TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 61 HARDNESS TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 62 FRIABILITY TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 63 OTHER BATCH-RELEASE TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 64 STABILITY TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 65 STABILITY TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 66 DRUG SUBSTANCE STABILITY TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 67 FORMULATION EVALUATION STABILITY TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 68 ACCELERATED STABILITY TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 69 PHOTOSTABILITY TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 70 FORCED DEGRADATION TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 71 OTHER STABILITY TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 72 MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 73 MICROBIAL TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 74 STANDARD LIMITS FOR MICROBIAL LIMIT TESTING
  • TABLE 75 MICROBIAL LIMIT TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 76 VIROLOGY TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 77 STERILITY TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 78 ENDOTOXIN TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 79 PRESERVATIVE EFFICACY TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 80 OTHER MICROBIAL TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 81 ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 82 ENVIRONMENTAL MONITORING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 83 PURITY CLASSES FOR PARTICLES, WATER, AND OIL IN COMPRESSED AIR
  • TABLE 84 AIR TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 85 STANDARDS FOR WASTEWATER QUALITY
  • TABLE 86 WASTEWATER/ETP SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 87 OTHER ENVIRONMENTAL MONITORING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 88 GENOMIC TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 89 OTHER ANALYTICAL TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 90 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 91 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 92 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 93 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 94 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 95 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR FORENSIC LABS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 96 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR COSMETIC & NUTRACEUTICAL COMPANIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 97 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 98 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 99 NORTH AMERICA: KEY MACROINDICATORS
  • TABLE 100 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 101 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 102 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 103 NORTH AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 104 NORTH AMERICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 105 NORTH AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 106 NORTH AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 107 NORTH AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 108 NORTH AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 109 NORTH AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 110 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 111 US: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 112 US: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 113 US: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 114 US: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 115 US: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 116 US: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 117 US: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 118 US: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 119 US: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 120 CANADA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 121 CANADA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 122 CANADA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 123 CANADA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 124 CANADA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 125 CANADA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 126 CANADA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 127 CANADA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 128 CANADA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 129 EUROPE: KEY MACROINDICATORS
  • TABLE 130 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 131 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 132 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 133 EUROPE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 134 EUROPE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 135 EUROPE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 136 EUROPE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 137 EUROPE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 138 EUROPE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 139 EUROPE: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 140 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 141 GERMANY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 142 GERMANY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 143 GERMANY: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 144 GERMANY: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 145 GERMANY: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 146 GERMANY: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 147 GERMANY: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 148 GERMANY: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 149 GERMANY: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 150 FRANCE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 151 FRANCE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 152 FRANCE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 153 FRANCE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 154 FRANCE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 155 FRANCE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 156 FRANCE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 157 FRANCE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 158 FRANCE: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 159 UK: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 160 UK: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 161 UK: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 162 UK: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 163 UK: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 164 UK: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 165 UK: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 166 UK: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 167 UK: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 168 ITALY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 169 ITALY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 170 ITALY: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 171 ITALY: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 172 ITALY: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 173 ITALY: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 174 ITALY: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 175 ITALY: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 176 ITALY: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 177 SWITZERLAND: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 178 SWITZERLAND: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 179 SWITZERLAND: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 180 SWITZERLAND: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 181 SWITZERLAND: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 182 SWITZERLAND: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 183 SWITZERLAND: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 184 SWITZERLAND: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 185 SWITZERLAND: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 186 SPAIN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 187 SPAIN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 188 SPAIN: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 189 SPAIN: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 190 SPAIN: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 191 SPAIN: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 192 SPAIN: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 193 SPAIN: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 194 SPAIN: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 195 REST OF EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 196 REST OF EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 197 REST OF EUROPE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 198 REST OF EUROPE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 199 REST OF EUROPE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 200 REST OF EUROPE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 201 REST OF EUROPE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 202 REST OF EUROPE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 203 REST OF EUR0PE: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 204 ASIA PACIFIC: MACROECONOMIC INDICATORS
  • TABLE 205 ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 206 ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 207 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 208 ASIA PACIFIC: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 209 ASIA PACIFIC: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 210 ASIA PACIFIC: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 211 ASIA PACIFIC: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 212 ASIA PACIFIC: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 213 ASIA PACIFIC: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 214 ASIA PACIFIC: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 215 ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 216 JAPAN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 217 JAPAN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 218 JAPAN: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 219 JAPAN: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 220 JAPAN: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 221 JAPAN: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 222 JAPAN: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 223 JAPAN: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 224 JAPAN: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 225 CHINA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 226 CHINA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 227 CHINA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 228 CHINA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 229 CHINA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 230 CHINA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 231 CHINA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 232 CHINA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 233 CHINA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 234 INDIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 235 INDIA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 236 INDIA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 237 INDIA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 238 INDIA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 239 INDIA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 240 INDIA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 241 INDIA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 242 INDIA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 243 AUSTRALIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 244 AUSTRALIA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 245 AUSTRALIA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 246 AUSTRALIA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 247 AUSTRALIA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 248 AUSTRALIA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 249 AUSTRALIA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 250 AUSTRALIA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 251 AUSTRALIA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 252 SOUTH KOREA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 253 SOUTH KOREA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 254 SOUTH KOREA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 255 SOUTH KOREA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 256 SOUTH KOREA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 257 SOUTH KOREA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 258 SOUTH KOREA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 259 SOUTH KOREA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 260 SOUTH KOREA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 261 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 262 REST OF ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 263 REST OF ASIA PACIFIC: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 264 REST OF ASIA PACIFIC: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 265 REST OF ASIA PACIFIC: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 266 REST OF ASIA PACIFIC: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 267 REST OF ASIA PACIFIC: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 268 REST OF ASIA PACIFIC: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 269 REST OF ASIA PACIFIC: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 270 LATIN AMERICA: KEY MACROINDICATORS
  • TABLE 271 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 272 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 273 LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 274 LATIN AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 275 LATIN AMERICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 276 LATIN AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 277 LATIN AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 278 LATIN AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 279 LATIN AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 280 LATIN AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 281 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 282 BRAZIL: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 283 BRAZIL: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 284 BRAZIL: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 285 BRAZIL: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 286 BRAZIL: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 287 BRAZIL: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 288 BRAZIL: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 289 BRAZIL: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 290 BRAZIL: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 291 MEXICO: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 292 MEXICO: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 293 MEXICO: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 294 MEXICO: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 295 MEXICO: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 296 MEXICO: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 297 MEXICO: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 298 MEXICO: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 299 MEXICO: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 300 REST OF LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 301 REST OF LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 302 REST OF LATIN AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 303 REST OF LATIN AMERICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 304 REST OF LATIN AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 305 REST OF LATIN AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 306 REST OF LATIN AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 307 REST OF LATIN AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 308 REST OF LATIN AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 309 MIDDLE EAST & AFRICA: KEY MACROINDICATORS
  • TABLE 310 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 311 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 312 MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 313 MIDDLE EAST & AFRICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 314 MIDDLE EAST & AFRICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 315 MIDDLE EAST & AFRICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 316 MIDDLE EAST & AFRICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 317 MIDDLE EAST & AFRICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 318 MIDDLE EAST & AFRICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 319 MIDDLE EAST & AFRICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 320 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 321 GCC COUNTRIES: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 322 GCC COUNTRIES: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 323 GCC COUNTRIES: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 324 GCC COUNTRIES: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 325 GCC COUNTRIES: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 326 GCC COUNTRIES: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 327 GCC COUNTRIES: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 328 GCC COUNTRIES: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 329 GCC COUNTRIES: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 330 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 331 REST OF MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 332 REST OF MIDDLE EAST & AFRICA: BUBIOANAZATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 333 REST OF MIDDLE EAST & AFRICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 334 REST OF MIDDLE EAST & AFRICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 335 REST OF MIDDLE EAST & AFRICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 336 REST OF MIDDLE EAST & AFRICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 337 REST OF MIDDLE EAST & AFRICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 338 REST OF MIDDLE EAST & AFRICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 339 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
  • TABLE 340 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DEGREE OF COMPETITION
  • TABLE 341 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: REGION FOOTPRINT
  • TABLE 342 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: TYPE FOOTPRINT
  • TABLE 343 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: END-USER FOOTPRINT
  • TABLE 344 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DETAILED LIST OF STARTUPS/SMES
  • TABLE 345 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: COMPETITIVE BENCHMARKING OF EMERGING PLAYERS/STARTUPS
  • TABLE 346 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: SERVICE LAUNCHES, JANUARY 2021-MAY 2025
  • TABLE 347 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DEALS, JANUARY 2021- JUNE 2025
  • TABLE 348 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: EXPANSIONS, JANUARY 2021- JUNE 2025
  • TABLE 349 EUROFINS SCIENTIFIC SE: COMPANY OVERVIEW
  • TABLE 350 EUROFINS SCIENTIFIC SE: SERVICES OFFERED
  • TABLE 351 EUROFINS SCIENTIFIC SE: DEALS, JANUARY 2021-JUNE 2025
  • TABLE 352 EUROFINS SCIENTIFIC SE: EXPANSIONS, JANUARY 2021-JUNE 2025
  • TABLE 353 LABCORP HOLDINGS INC.: COMPANY OVERVIEW
  • TABLE 354 LABCORP HOLDINGS INC.: SERVICES OFFERED
  • TABLE 355 LABCORP HOLDINGS INC.: SERVICE LAUNCHES, JANUARY 2021-JUNE 2025
  • TABLE 356 LABCORP HOLDINGS INC.: DEALS, JANUARY 2021-JUNE 2025
  • TABLE 357 LABCORP HOLDINGS INC.: EXPANSIONS, JANUARY 2021-JUNE 2025
  • TABLE 358 INTERTEK GROUP PLC: COMPANY OVERVIEW
  • TABLE 359 INTERTEK GROUP PLC: SERVICES OFFERED
  • TABLE 360 INTERTEK GROUP PLC: DEALS, JANUARY 2021-JUNE 2025
  • TABLE 361 INTERTEK GROUP PLC: EXPANSIONS, JANUARY 2021-JUNE 2025
  • TABLE 362 ICON PLC: COMPANY OVERVIEW
  • TABLE 363 ICON PLC: SERVICES OFFERED
  • TABLE 364 ICON PLC: DEALS, JANUARY 2021-JUNE 2025
  • TABLE 365 IQVIA INC.: COMPANY OVERVIEW
  • TABLE 366 IQVIA HOLDINGS INC.: SERVICES OFFERED
  • TABLE 367 IQVIA INC.: EXPANSIONS, JANUARY 2021-JUNE 2025
  • TABLE 368 IQVIA INC.: OTHER DEVELOPMENTS, JANUARY 2021-JUNE 2025
  • TABLE 369 WUXI APPTEC CO., LTD.: COMPANY OVERVIEW
  • TABLE 370 WUXI APPTEC CO., LTD.: SERVICES OFFERED
  • TABLE 371 WUXI APPTEC CO., LTD.: SERVICE LAUNCHES, JANUARY 2021-JUNE 2025
  • TABLE 372 WUXI APPTEC CO., LTD.: DEALS, JANUARY 2021-JUNE 2025
  • TABLE 373 WUXI APPTEC CO., LTD.: EXPANSIONS, JANUARY 2021-JUNE 2025
  • TABLE 374 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
  • TABLE 375 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: SERVICES OFFERED
  • TABLE 376 CHARLES RIVER LABORATORIES: SERVICE LAUNCHES & APPROVALS, JANUARY 2021-JUNE 2025
  • TABLE 377 CHARLES RIVER LABORATORIES: DEALS, JANUARY 2021-JUNE 2025
  • TABLE 378 CHARLES RIVER LABORATORIES: EXPANSIONS, JANUARY 2021-JUNE 2025
  • TABLE 379 SGS SA: COMPANY OVERVIEW
  • TABLE 380 SGS SA: SERVICES OFFERED
  • TABLE 381 SGS SA: SERVICE LAUNCHES, JANUARY 2021-JUNE 2025
  • TABLE 382 SGS SA: DEALS, JANUARY 2021-JUNE 2025
  • TABLE 383 SGS SA: EXPANSIONS, JANUARY 2021-JUNE 2025
  • TABLE 384 SGS SA: OTHER DEVELOPMENTS, JANUARY 2021-JUNE 2025
  • TABLE 385 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 386 THERMO FISHER SCIENTIFIC INC.: SERVICES OFFERED
  • TABLE 387 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-JUNE 2025
  • TABLE 388 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021-JUNE 2025
  • TABLE 389 MEDPACE HOLDINGS, INC.: COMPANY OVERVIEW
  • TABLE 390 MEDPACE HOLDINGS, INC.: SERVICES OFFERED
  • TABLE 391 MEDPACE HOLDINGS, INC.: DEALS, JANUARY 2021-JUNE 2025
  • TABLE 392 MEDPACE HOLDINGS, INC.: EXPANSIONS, JANUARY 2021-JUNE 2025
  • TABLE 393 SARTORIUS AG: COMPANY OVERVIEW
  • TABLE 394 SARTORIUS AG: SERVICES OFFERED
  • TABLE 395 SARTORIUS AG: DEALS, JANUARY 2021-JUNE 2025
  • TABLE 396 SARTORIUS AG: EXPANSIONS, JANUARY 2021-JUNE 2025
  • TABLE 397 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 398 MERCK KGAA: SERVICES OFFERED
  • TABLE 399 MERCK KGAA: SERVICE LAUNCHES, JANUARY 2021-JUNE 2025
  • TABLE 400 MERCK KGAA: DEALS, JANUARY 2021-JUNE 2025
  • TABLE 401 MERCK KGAA: EXPANSIONS, JANUARY 2021-JUNE 2025
  • TABLE 402 MERCK KGAA: OTHER DEVELOPMENTS, JANUARY 2021-JUNE 2025
  • TABLE 403 SOURCEBIO INTERNATIONAL PLC: COMPANY OVERVIEW
  • TABLE 404 SOURCEBIO INTERNATIONAL PLC: SERVICES OFFERED
  • TABLE 405 SOURCEBIO INTERNATIONAL PLC: SERVICE LAUNCHES, JANUARY 2021-JUNE 2025
  • TABLE 406 SOURCEBIO INTERNATIONAL PLC: EXPANSIONS, JANUARY 2021-JUNE 2025
  • TABLE 407 ALS: COMPANY OVERVIEW
  • TABLE 408 ALS: SERVICES OFFERED
  • TABLE 409 ALS: DEALS, JANUARY 2021-JUNE 2025
  • TABLE 410 FRONTAGE LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 411 FRONTAGE LABORATORIES, INC.: SERVICES OFFERED
  • TABLE 412 FRONTAGE LABORATORIES, INC.: DEALS, JANUARY 2021-JUNE 2025
  • TABLE 413 FRONTAGE LABORATORIES, INC.: EXPANSIONS, JANUARY 2021-JUNE 2025
  • TABLE 414 STERIS: COMPANY OVERVIEW
  • TABLE 415 STERIS PLC: SERVICES OFFERED
  • TABLE 416 STERIS PLC: SERVICE LAUNCHES, JANUARY 2021-JUNE 2025
  • TABLE 417 STERIS PLC: EXPANSIONS, JANUARY 2021-JUNE 2025
  • TABLE 418 STERIS PLC: OTHER DEVELOPMENTS, JANUARY 2021-JUNE 2025
  • TABLE 419 ELEMENT MATERIALS TECHNOLOGY: COMPANY OVERVIEW
  • TABLE 420 ELEMENT MATERIALS TECHNOLOGY: SERVICES OFFERED
  • TABLE 421 ELEMENT MATERIALS TECHNOLOGY: SERVICE LAUNCHES, JANUARY 2021-JUNE 2025
  • TABLE 422 ELEMENT MATERIALS TECHNOLOGY: DEALS, JANUARY 2021-JUNE 2025
  • TABLE 423 ELEMENT MATERIALS TECHNOLOGY: EXPANSIONS, JANUARY 2021-JUNE 2025
  • TABLE 424 ELEMENT MATERIALS TECHNOLOGY: OTHER DEVELOPMENTS, JANUARY 2021-JUNE 2025
  • TABLE 425 PACE ANALYTICAL SERVICES: COMPANY OVERVIEW
  • TABLE 426 PACE ANALYTICAL SERVICES: SERVICES OFFERED
  • TABLE 427 PACE ANALYTICAL SERVICES: DEALS, JANUARY 2021-JUNE 2025
  • TABLE 428 PACE ANALYTICAL SERVICES: EXPANSIONS, JANUARY 2021-JUNE 2025
  • TABLE 429 ALMAC GROUP: COMPANY OVERVIEW
  • TABLE 430 ALMAC GROUP: SERVICES OFFERED
  • TABLE 431 ALMAC GROUP: SERVICE APPROVALS, JANUARY 2021-JUNE 2025
  • TABLE 432 ALMAC GROUP: DEALS, JANUARY 2021-JUNE 2025
  • TABLE 433 ALMAC GROUP: EXPANSIONS, JANUARY 2021-JUNE 2025
  • TABLE 434 PHARMARON BEIJING CO., LTD.: COMPANY OVERVIEW
  • TABLE 435 PHARMARON BEIJING CO., LTD.: SERVICES OFFERED
  • TABLE 436 PHARMARON BEIJING CO., LTD.: DEALS, JANUARY 2021-JUNE 2025
  • TABLE 437 SYNEOS HEALTH: COMPANY OVERVIEW
  • TABLE 438 PAREXEL INTERNATIONAL (MA) CORPORATION: COMPANY OVERVIEW
  • TABLE 439 LGC LIMITED: COMPANY OVERVIEW
  • TABLE 440 CELERION: COMPANY OVERVIEW
  • TABLE 441 BIOAGILYTIX: COMPANY OVERVIEW
  • TABLE 442 ALCAMI CORPORATION: COMPANY OVERVIEW
  • TABLE 443 SAMSUNG BIOLOGICS: COMPANY OVERVIEW
  • TABLE 444 CURIA GLOBAL, INC.: COMPANY OVERVIEW
  • TABLE 445 BA SCIENCES: COMPANY OVERVIEW
  • TABLE 446 AVANCE BIOSCIENCES: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 MARKET & GEOGRAPHIC SEGMENTATION
  • FIGURE 2 REGIONAL SEGMENTATION
  • FIGURE 3 HEALTHCARE ANALYTICAL TESTING MARKET: RESEARCH METHODOLOGY
  • FIGURE 4 RESEARCH DESIGN
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 7 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 8 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 9 REVENUE SHARE ANALYSIS: COMPANY ILLUSTRATION
  • FIGURE 10 TOP-DOWN APPROACH
  • FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 12 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: CAGR PROJECTIONS, 2025-2030
  • FIGURE 13 DATA TRIANGULATION METHODOLOGY
  • FIGURE 14 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 16 PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 18 GEOGRAPHIC SNAPSHOT OF HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
  • FIGURE 19 RISING NUMBER OF CLINICAL TRIALS AND GROWING OUTSOURCING OF PHARMA R&D SERVICES TO CROS TO PROPEL MARKET
  • FIGURE 20 BIOANALYTICAL TESTING SERVICES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN GERMANY IN 2O24
  • FIGURE 21 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 22 NORTH AMERICA REGION TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 23 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24 INCREASING NUMBER OF CLINICAL TRIALS WORLDWIDE (2004-2024)
  • FIGURE 25 PERCENTAGE OF REGISTERED STUDIES BY LOCATION (AS OF 2024)
  • FIGURE 26 PHARMACEUTICAL & BIOPHARMACEUTICAL R&D EXPENDITURE, 2002-2024
  • FIGURE 27 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 28 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 29 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HEALTHCARE ANALYTICAL TESTING SERVICES
  • FIGURE 31 KEY BUYING CRITERIA FOR HEALTHCARE ANALYTICAL TESTING SERVICES, BY END USER
  • FIGURE 32 REVENUE SHIFT IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
  • FIGURE 33 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: NUMBER OF DEALS, BY KEY PLAYER, 2019-2023 (USD MILLION)
  • FIGURE 34 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019-2023 (USD MILLION)
  • FIGURE 35 VALUE OF INVESTOR DEALS IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY KEY PLAYER, 2019-2023 (USD MILLION)
  • FIGURE 36 USE OF GEN AI ON HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
  • FIGURE 37 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
  • FIGURE 38 ASIA PACIFIC: HEALTHCARE ANALYTICS TESTING SERVICES MARKET SNAPSHOT
  • FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, 2020-2024
  • FIGURE 40 MARKET SHARE ANALYSIS OF KEY PLAYERS IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET (2024)
  • FIGURE 41 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 42 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: COMPANY FOOTPRINT
  • FIGURE 43 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 44 EV/EBITDA OF KEY VENDORS
  • FIGURE 45 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 46 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: BRAND/SERVICE COMPARATIVE ANALYSIS
  • FIGURE 47 EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2024)
  • FIGURE 48 LABCORP HOLDINGS INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 49 INTERTEK GROUP PLC: COMPANY SNAPSHOT (2024)
  • FIGURE 50 ICON PLC: COMPANY SNAPSHOT (2024)
  • FIGURE 51 IQVIA INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 52 WUXI APPTEC CO., LTD.: COMPANY SNAPSHOT (2024)
  • FIGURE 53 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2024)
  • FIGURE 54 SGS SA: COMPANY SNAPSHOT (2024)
  • FIGURE 55 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 56 MEDPACE HOLDINGS, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 57 SARTORIUS AG: COMPANY SNAPSHOT (2024)
  • FIGURE 58 MERCK KGAA: COMPANY SNAPSHOT (2024)
  • FIGURE 59 ALS: COMPANY SNAPSHOT (2024)
  • FIGURE 60 FRONTAGE LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 61 STERIS PLC: COMPANY SNAPSHOT (2024)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!